Bile acids and the Risk for Hepatocellular Carcinoma in Primary Biliary Cholangitis
Journal Title: Annals of Hepatology - Year 2016, Vol 15, Issue 3
Abstract
This article does not has abstract.
Authors and Affiliations
Alejandra Altamirano-Barrera, Misael Uribe, Frank Lammert, Nahum Méndez-Sánchez
Keywords
Related Articles
- EP ID EP78589
- DOI 10.5604/16652681.1198826
- Views 128
- Downloads 0
Successful antiviral treatment of chronic hepatitis C in patients with rare comorbidities. Two case-reports
Antiviral therapy in patients suffering from chronic hepatitis C virus (HCV) infection and rare comorbidities cannot be easily started, as it can reduce the likelihood of a good therapeutic response with an increased fre...
Methodology of Diagnostic Tests in Hepatology
The performance of diagnostic tests can be assessed by a number of ethods. These include sensitivity, specificity,positive and negative predictive values, likelihood ratios and receiver operating characteristic (ROC) cur...
Molecular and serological characterization of occult hepatitis B infection in blood donors from Mexico
Occult hepatitis B virus (HBV) infection (OBI) is characterized by presence of HBV DNA in blood or liver tissue without detectable HBV surface antigen (HBsAg), with or without antibodies to hepatitis B core antigen (anti...
Acute liver failure in under two year-olds - are there markers of metabolic disease on admission?
Introduction. The early establishment of an etiology for acute liver failure (ALF) in infants is essential for the start of adequate treatment in the shortest timeframe possible.Aim. To identify markers of inherited meta...
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy
Hyperammonemia and associated cerebral edema cause neurological abnormalities in liver disease patients. Although only 15% of ammonia production originates in the colon, management strategies for hepatic encephalopathy (...